Professional Documents
Culture Documents
2 Pharmacology of Chemotherapeutics
2 Pharmacology of Chemotherapeutics
8
Chemotherapy – single agents:
Alkylating agents - act by linking guanine molecules on opposing
strands of the DNA helix, preventing the DNA from uncoiling and thereby
halting cell division
Cyclophosphamide, ifosfamide, dacarbazine, temozolomide (Temodal®)
9 Doxorubicin
Chemotherapy – single agents:
Topoisomerase inhibitors – block the enzyme topoisomerase,
which is essential for uncoiling DNA during cell replication
Etoposide, irinotecane
• Etoposide: risk of lowered blood pressure during infusion
Platinums – damage DNA cells and stop them from dividing
Carboplatin, cisplatin
• Cisplatin: Very emetogenic, as well as risk of kidney damage and
hearing loss
Carboplatin Cisplatin
10
Chemotherapy – single agents:
Mitotic inhibitors – block cell growth by stopping mitosis (cell
division)
• Taxanes – paclitaxel, docetaxel, Abraxane
• Vinca alkaloids – vinorelbine, vinblastine, vincristine
– Can be neurotoxic, both reversible and sometimes irreversible – ask the
patient about changed feeling in their hands or feet.
– Should NEVER be given intrathecally! It is in most cases fatal
11
Chemotherapy – combinations:
– CAF = cyclophosphamide + Adriamycin®(doxorubicin) + 5-fluorouracil
– TAC = Taxotere®(docetaxel) + Adriamycin® (doxorubicin)+cyclophosphamide
– AC-T = cyclophosphamide + Adriamycin®(doxorubicin) + Taxol®(paclitaxel)
– AC = cyclophosphamide + Adriamycin®(doxorubicin)
– CMF = cyclophosphamide + methotrexate + 5-fluorouracil
– Adriamycin®(doxorubicin) + Taxol®(paclitaxel)
– Taxotere® (docetaxel) + Xeloda® (capecitabine)
– Flox: Oxaliplatin + 5-fluoruracil + leucovorin
– Fliri: Irinotekan + 5-fluoruracil + leucovorin
12
Combination therapy – never several
drugs the same drug class
Alkylating agents Antimetabolites Cytotoxic
antibiotics
Folic acid antagonists Pyrimidine Purine antagonists (anthracyclines)
antagonists
15
Hormone Therapy
16
Steroids – glucocorticoids
E.g. prednisolone, prednisone and
dexamethasone
• Not cytotoxic drugs
• Hormones that have an immunosuppresive
and anti inflammatory effect
• Inhibits cell proliferation and leads to cell
death
• lymphatic leukaemia cancer cells are very
sensitive to steroids
• Counteracts cerebral edema
• Often used as anti emetics
• Have several side effects, as shown in the
figure
Drug interactions
Drug Interactions
A drug interaction is defined by an alteration of
one drug by another drug or by the presence of
some other substance.
– The Drug whose activity is effected by such an
interaction is called as a “Object drug”.
– The agent which precipitates such an interaction is
referred to as the “Precipitant”.
19
Types of drug interactions
1. Drug-drug interactions.
2. Drug-food interactions (alcohol and smoking may also influence)
3. Chemical-drug interactions.
4. Drug-laboratory test interactions.
5. Drug-disease interactions.
• Note! Be aware of drug interactions with herbal medicine e.g. St.
John`s Wort
• Read carefully the medicinal drug summary of product characteristics
and/or label for information on specific drug interactions!
20
Classification of drug Dose
interactions Pharmacokinetic
variability
• Absorption
• Pharmacodynamic • Distribution
• Metabolism
• Excretion
interactions
Plasma
• Pharmacokinetic concentration
interactions Pharmacodynamic
variability
• Receptor
• Pharmaceutical interactions
• Receptor
response
interactions
Clinical effect
21
Pharmacodynamic interactions
These interactions arise when a drug indirectly
or directly affect the drug at its site of action.
In these types of interactions there is no change
in drug concentration.
Examples:
• Administration of two blood thinners will often lead
to bleeding
• Administration of two anti hypertensive medicines
can lead to low bloodpressure
22
Direct pharmacodynamic interactions
Interactions where drugs that have similar or opposing
pharmacological effects are used concurrently. The three
consequences of direct interactions are:
• Antagonism - The interacting drugs have opposing actions
– Acetylcholine and noradrenaline have opposing effects on heart rate
• Addition or summation - The interacting drugs have similar actions
and the resulting effect is the sum of individual drug responses
– Administering two CNS depressants like sedatives and hypnotics
• Synergism or potentiation - Enhancement of action of one drug by
another
– Administering leucovorin concomitant to fluorouracil increases the cytotoxic
effect of fluorouracil
23
Pharmacokinetic interactions
These interactions arise when a drug changes
the absorption, distribution, metabolism or
excretion of another drug.
This type of interaction will change the plasma
concentration of the drug in the body.
Examples:
• NSAIDS and methotrexate
NSAIDS inhibits renal prostaglandin synthesis leads to
reduced renal perfusion which reduces the renal
excretion of methotrexate. Important to remember for
high dose MTX and kidney problems.
24
Types of pharmacokinetic
interactions
• Absorption interactions
• Faster or slower absorption
• More or less complete absorption
• Distribution interactions
• Plasma protein binding
• Metabolic interactions
• Enzymatic inhibition or induction
• Excretion interactions
• Influencing the kidneys or the bile
Major mechanisms of absorption
interactions
1. Complexation and adsorption.
2. Alteration in GI pH.
3. Alteration in gut motility.
4. Inhibition of GI enzymes
5. Alteration of GI micro flora.
6. Malabsorption syndrome.
26
Distribution interactions
Interactions where the distribution pattern of the object
drug is altered
The major mechanism for distribution interaction is
alteration in protein-drug binding.
• Leading to more drug available in the body than
normal, and therefore increased effect
Displaced drug Displacer Clinical effect
27
Metabolic interactions
28
Excretion interactions
29
Pharmaceutical interactions
Also called incompatibility.
31
Drug interactions are thus:
• Mostly undesirable and can give clinically very
severe consequences for a patient if they are not
handled correctly
• Rarely desirable (beneficial): for eg.,enhancement
of activity of penicillin when administered with
probenecid.
32
Factors contributing to drug interactions:
1. Multiple drug therapy.
2. Multiple prescribers.
3. Multiple pharmacological effects of drug.
4. Multiple diseases/predisposing illness.
5. Poor patient compliance.
6. Advancing age of patient.
33
Reducing the risk of interactions
1. Identify the patients risk
factors.
2. Take a thorough drug history of
your patient.
3. Have knowledge about the
actions of the drugs being used.
4. Consider therapeutic
alternatives.
5. Avoid complex therapeutic
regiments when possible.
6. Educate the patient.
7. Monitor therapy.
34